Achyut Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.20 M
- Paid Up Capital ₹ 4.20 M
- Company Age 11 Year, 4 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 5.00 M
- Revenue Growth 54.59%
- Profit Growth 843.21%
- Ebitda 454.24%
- Net Worth 1058.00%
- Total Assets -15.47%
About Achyut Pharma
Achyut Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 February 2014 and has a history of 11 years. Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.20 M and a paid-up capital of Rs 4.20 M.
The company currently has active open charges totaling ₹5.00 M.
Malhar Ardesana, Vishal Sorathia, Jay Sojitra, and Two other members serve as directors at the Company.
Company Details
-
Location
Rajkot, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2014PTC078573
-
Company No.
078573
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Feb 2014
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Achyut Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Kiritbhai
|
Director | 04-Feb-2014 | Current |
|
Jay Sojitra
|
Director | 04-Feb-2014 | Current |
|
Malhar Ardesana
|
Director | 04-Feb-2014 | Current |
|
Vishal Sorathia
|
Director | 09-Feb-2016 | Current |
|
Prabhaben Ardesana
|
Director | 04-Feb-2014 | Current |
Financial Performance of Achyut Pharma.
Achyut Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 54.59% increase. The company also saw a substantial improvement in profitability, with a 843.21% increase in profit. The company's net worth Soared by an impressive increase of 1058%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Achyut Pharma?
In 2020, Achyut Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sansiddhi Technocast Private LimitedVishal Sorathia is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2015 | State Bank Of India | ₹5.00 M | Open |
How Many Employees Work at Achyut Pharma?
Unlock and access historical data on people associated with Achyut Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Achyut Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Achyut Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
